- Home
- TECH vs VNO Comparison
TECH vs VNO Comparison
Compare TECH & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- VNO
- Stock Information
- Founded
- TECH 1976
- VNO 1946
- Country
- TECH United States
- VNO United States
- Employees
- TECH 3100
- VNO N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- VNO Real Estate Investment Trusts
- Sector
- TECH Health Care
- VNO Real Estate
- Exchange
- TECH Nasdaq
- VNO Nasdaq
- Market Cap
- TECH 7.8B
- VNO 7.0B
- IPO Year
- TECH 1989
- VNO N/A
- Fundamental
- Price
- TECH $48.34
- VNO $39.46
- Analyst Decision
- TECH Buy
- VNO Hold
- Analyst Count
- TECH 10
- VNO 11
- Target Price
- TECH $73.44
- VNO $38.00
- AVG Volume (30 Days)
- TECH 2.4M
- VNO 1.3M
- Earning Date
- TECH 05-07-2025
- VNO 05-05-2025
- Dividend Yield
- TECH 0.66%
- VNO 1.87%
- EPS Growth
- TECH N/A
- VNO 248.25
- EPS
- TECH 0.83
- VNO 0.52
- Revenue
- TECH $1,208,770,000.00
- VNO $1,929,890,000.00
- Revenue This Year
- TECH $8.19
- VNO N/A
- Revenue Next Year
- TECH $8.61
- VNO $5.12
- P/E Ratio
- TECH $58.36
- VNO $75.33
- Revenue Growth
- TECH 4.72
- VNO 2.98
- 52 Week Low
- TECH $46.44
- VNO $22.42
- 52 Week High
- TECH $85.57
- VNO $46.63
- Technical
- Relative Strength Index (RSI)
- TECH 39.46
- VNO 61.24
- Support Level
- TECH $46.77
- VNO $38.63
- Resistance Level
- TECH $54.40
- VNO $40.73
- Average True Range (ATR)
- TECH 2.15
- VNO 1.20
- MACD
- TECH 0.23
- VNO 0.40
- Stochastic Oscillator
- TECH 8.82
- VNO 81.81
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.